Background. The cause of cellulitis is unclear. Streptococcus pyogenes, and to a lesser extent, Staphylococcus aureus, are presumed pathogens.
The cause of cellulitis, which is characterized inflammation and presumed infection of the skin and subcutaneous tissue in the absence of a wound infection or abscess, is unclear. Previous studies have analyzed biopsy and needle aspirate specimens by conventional culture [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Specimen yield has been low, with about 16% demonstrating growth, typically Staphylococcus aureus and Streptococcus pyogenes (group A streptococcus) [19] . Although S. aureus has been the most frequently identified isolate in these studies, results of tissue immunofluorescence and serological studies [20] [21] [22] [23] [24] , along with small clinical trials [24, 25] , have suggested that S. pyogenes is the predominant pathogen. Recently, community-associated methicillin-resistant S. aureus (MRSA) has emerged as a common cause of purulent skin infections in many parts of the world [26] . One retrospective study of patients with cellulitis found that treatment with antimicrobials that have MRSA activity was associated with a higher success rate than treatment with antimicrobials lacking such activity [27] . Therefore, optimal treatment of cellulitis without drainage is unclear. Infectious Diseases Society of America practice guidelines primarily recommend antimicrobial agents active against S. pyogenes, with regimens also active against MRSA for patients at higher risk for this pathogen or with severe illness [28] .
Conventional culture may fail to identify bacteria that are low in number, fastidious, or from patients previously treated with antimicrobials. Molecular diagnostic methods, such as direct 16S ribosomal DNA polymerase chain reaction (PCR) amplification and pyrosequencing, have been used to address the limitations of culture-based techniques [29, 30] . A wide range of pathogens can be detected by comparing PCR amplified DNA from specimens across large clonal libraries and pyrosequencing of individual molecules within PCR products. The cause of cellulitis has yet to be evaluated using these techniques.
The primary goal of this study was to investigate the cause of acute cellulitis without drainage by testing skin biopsy specimens from the infected site and a comparable uninfected site by quantitative PCR, pyrosequencing, and conventional culture. To determine the cause, we compared the relative predominance and quantity of bacterial species in tissue specimens collected from the infected and uninfected sites.
METHODS

Patients and Study Oversight
We conducted a prospective study of patients aged >17 years with the clinical diagnosis of cellulitis without drainage who presented to a US emergency department-based research network, EMERGEncy ID NET [31] , between April 2009 and November 2011. All site institutional review boards approved the study.
Inclusion criteria were as follows: clinical diagnosis of cellulitis with erythema and of warmth, swelling, and/or tenderness, without drainage or a wound, such that the patient's treating clinician intends to treat with antibiotic; erythema dimension >3 cm; symptoms for <7 days; agreement to be contacted within 2-3 days; and willingness to provide written informed consent. Patients could not have any of the following exclusion criteria: abscess based on clinical examination and soft-tissue ultrasound; current clinical trial participation; head, hand, foot, or perineal location of infection; infection due to a mammalian bite or injection drug use; known immunodeficiency (ie, absolute neutrophil count <500/mm 3 , immunosuppressive drugs, active chemotherapy, human immunodeficiency virus infection with CD4 cell count <200/mm 3 , or history of AIDS-defining illness); burn or active chronic skin condition; infection associated with percutaneous prosthetic device or suspected osteomyelitis or septic arthritis; infection associated with diabetic foot, decubitus, or ischemic ulcer; coagulopathy; severe peripheral vascular disease; antimicrobial use within 72 hours; and infection where a punch biopsy could not be easily obtained.
Data Collection
The patient's treating physician completed a standardized form at the time of care and recorded the following patient data: age, sex, race, infection duration, antimicrobial use and type within the last 30 days, history of chills, sweats or rigors, complaint of severe pain, maximal measured temperature, location, length and width of erythema, presence of lymphangitis, disposition, and antimicrobial treatment. The patient's treating physician directed their medical care and study-associated culture and molecular study results were not provided. After specimens were obtained, all subjects received antibiotic treatment. Study assistants contacted patients 2-3 days after their index visit to evaluate treatment response and biopsy complications.
A punch biopsy was obtained from the center of the infected site and from a comparable uninfected site on the opposite side of the body. A needle aspirate specimen was also obtained from the infected site to determine if it could be a less invasive proxy for punch biopsy. Details of these methods can be found in an online training video (https://youtube/LsX58tQt8YA?t=32) that investigators completed before enrolling patients. Tissue aspirate and biopsy specimens were placed directly into anaerobic transport medium (AS-911 and AS-919; Anaerobe Systems) and shipped overnight to the Veterans Administration Medical Center West Los Angeles laboratory. Details concerning microbiology, PCR, and pyrosequencing testing are provided in the Supplementary Methods [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] .
Statistical Analysis
Simple descriptive statistics were calculated (J. G. C., S. S. T., and A. K.) using Stata Version 12 (StataCorp) and Microsoft Excel (Microsoft) software.
RESULTS
Fifty-one patients were enrolled. Specimens from 1 patient were lost during processing. Characteristics of the study population are described in Table 1 . Among 50 subjects, the median age was 46 years (interquartile range [IQR], 35-57 years; range, 22-74 years), and the median maximal erythema dimension was 24 cm (IQR, 12-35 cm; range, 3-63 cm); 19 (38%) of the subjects were hospitalized. Because of transport tube damage, PCR was not performed on 1 subject's uninfected site biopsy specimen, and pyrosequencing was not done for 2 subjects' infected site aspirate specimens and another subject's uninfected site biopsy specimen.
Among 50 subjects with cultures of infected site biopsy specimens, 42 (84%) had no growth, and most isolated organisms seemed to be skin colonizers or contaminants (Table 2) . Methicillin-susceptible S. aureus (MSSA) was isolated in 2 subjects (4%). These isolates had growth concentrations of 1 × 10 8 and 3 × 10 4 colony forming units (CFUs)/mL. In these subjects, there was no growth from uninfected site specimens. Both subjects had MSSA detected with PCR but not with pyrosequencing. In another subject's aspirate specimen, Pseudomonas aeruginosa grew at 1 × 10 5 CFUs/mL. Pseudomonas aeruginosa was not detected by PCR or pyrosequencing. Neither MRSA nor S. pyogenes was isolated by culture from any subject's infected tissue specimen. PCR results are shown in Table 3 . Among 49 subjects with paired infected and uninfected biopsy specimen PCR results, MSSA was identified from the infected site in 20 subjects (41%), and from the uninfected site in 17 (35%); MSSA was present only in the infected site in 14, only in the uninfected site in 11, and in both in 6. MSSA was detected at a density of approximately 1 × 10 4 . Finegoldia magna was found at low levels (approximately 1 × 10
2 ) only in the infected site in 9 subjects (18%), only in the uninfected site in 8 (16%), and in both in 15 (31%). Streptococcus agalactiae and Streptococcus anginosus were rarely detected. MRSA and S. pyogenes were not found with PCR in any infected site biopsy specimen. Pyrosequencing yielded 648 bacterial species, ranging from 1 to 73 species per subject, with a median of 20 species (IQR, 14-24) per infected and 19 (IQR, 14-24) per uninfected site specimen. The 2 bacterial species present in highest concentration from each subject's specimen are provided in Supplemental Table 2 . Among 49 subjects with paired infected and uninfected biopsy site specimens tested with pyrosequencing, S. aureus was identified in 12 (24%) and 16 (33%) of the infected and uninfected site specimens and streptococci in 15 (31%) and 20 (41%), respectively. Staphylococcus aureus was present only in the infected site in 2 subjects, only in the uninfected site in 6, and in both in 10. Streptococcus pyogenes was not identified in any specimen.
Results of needle aspirate and biopsy specimens from the infected site were discordant across all pathogen identification techniques (Table 3 and Supplemental Table 2 ).
DISCUSSION
To our knowledge, this is the first study to employ molecular diagnostic techniques of PCR and pyrosequencing to determine the cause of acute cellulitis without drainage. Using these techniques along with conventional cultures to detect and compare the amount and frequency of bacteria in biopsy specimens from infected and uninfected tissue, we were unable to identify any specific pathogen(s) or validate the presumed role of S. pyogenes and S. aureus as the predominant cause of cellulitis. We confirmed past studies that found low rates of bacterial growth using standard culture [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . PCR identified MSSA from about 30%-40% of cases with similar frequency from infected and uninfected sites. Pyrosequencing identified abundant atypical organisms, including staphylococci and streptococci, yet no outstanding representation of any particular species. From infected site specimens, S. pyogenes was not identified by any technique, and MRSA was not identified by techniques that could discriminate it from MSSA, that is, culture or PCR. A review of 16 studies from 1966 through 2007 that used needle aspiration or biopsy to evaluate the cause of cellulitis found that, of 808 subjects, 129 (16%) had positive cultures. Among specimens showing growth, S. aureus was isolated in 50%, S. pyogenes in 27%, and other pathogens in 27% [19] . The low yield of conventional cultures has been attributed to low bacterial densities [15] . We took specimens from the center of the lesion because in cellulitis, there is often no distinct leading edge, although the optimal site (ie, the center or leading edge) has been debated [15] . No patient had taken antimicrobials within 72 hours of specimen acquisition. We immediately placed specimens in anaerobic transport media and delivered these overnight for nextday incubation, which has been demonstrated to reliably maintain organism viability from typical clinical specimens [42] .
Lidocaine, which was used in our study, has been demonstrated to possess antimicrobial activity [15, 43, 44] . Its antimicrobial activity seems to be enhanced by preservative; therefore, we used a preservative-free solution. Lidocaine's effect may be greater against S. pyogenes than against S. aureus, but the yield seems to be unaffected within 2 hours of exposure [15] . Lidocaine would not be expected to interfere with the integrity of DNA, but, to our knowledge, its effect on PCR and pyrosequencing assays has not been investigated. In studies in which cellulitis tissue specimens have been obtained without lidocaine, culture yield has been found to be similarly low [15] .
PCR-amplified 16S ribosomal DNA sequencing can enhance detection of bacteria that are difficult to grow. PCR has been demonstrated to be accurate in S. aureus identification from infected wound drainage compared against culture results [45] . However, it is limited by the range of available primers and thus may not identify the full range of flora. Similar to the low yield by standard cultures, we found PCR yield to be low. We used 1 × 10 5 CFUs/mL as the cutoff for significant amplification, but lower thresholds would still not have identified any causative agents. Pyrosequencing provides a large number of sequence readings in a single run, allowing detection of the smallest quantities of species. It was recently applied to brain abscess specimens and revealed more organisms than previously reported, including many anaerobes and uncultured oral bacteria and newly described involvement of Mycoplasma species [29] . In our study, each specimen subjected to pyrosequencing revealed numerous bacterial species, including many not associated with human infections. The role of these unrecognized organisms in the pathogenesis of cellulitis is unclear because none seemed to be uniquely represented from infected tissue. Molecular techniques also have limitations, including amplification biases due to selected primer mismatches and restricted phylogenetic resolving power and disproportionately exaggerated sequencing errors with pyrosequencing [30] . Specific strain virulence factors cannot be assessed. Tissue has been demonstrated to interfere with amplification assays [46, 47] .
The absence of detection of S. pyogenes with culture, PCR, and pyrosequencing is remarkable. This organism was not detected despite use of a specific PCR primer, and the fact that many other streptococcal species were detected with pyrosequencing. PCR primers and probes designed in our laboratory went through rigorous performance testing and, with regard to S. pyogenes isolates from wound infections detected by conventional culture, PCR demonstrated 100% sensitivity ( personal communication, S. M. F. and P. H. S.). Streptococcus pyogenes has been found using direct immunofluorescence of cellulitis tissue specimens, and evidence of infection has been supported by serum serology (eg, antistreptolysin test) [20] [21] [22] [23] [24] . However, the specificity of these techniques is unclear; to our knowledge, they have not been evaluated in skin infections for which other pathogens can be cultured (eg, using immunofluorescence of surrounding cellulitis or serum serology associated with abscesses).
Small clinical trials employing cefazolin or cephalexin suggest a possible role for streptococci, but also MSSA, as opposed to MRSA, for patients with cellulitis [24, 25] . A review of blood cultures among patients with cellulitis revealed that 125 (7.9%) of 1578 patients had positive blood cultures, 24 (19%) positive for S. pyogenes and 38 (38%) for other β-hemolytic streptococci [48] . Streptococcus pyogenes was found somewhat more often as a cause of bacteremia in patients with cellulitis lesions that had a distinct leading edge characterized as erysipelas, a distinction we did not make in our study. Streptococcus pyogenes may also be disproportionately associated with more severe infection. Although our emergency department study population had a relatively high hospitalization rate and large areas of cellulitis, only 14% had fever and none had necrotizing fasciitis; therefore, this group may not have been sufficiently ill that S. pyogenes was frequently involved.
Staphylococcus aureus was detected with all techniques, and MSSA, but not MRSA, with culture and PCR. If molecular techniques cannot discriminate infection from colonization by frequency or quantity of detection, or if infection is driven by specific strain virulence factors or local host immune response independent of pathogen density, MSSA could be a pathogen in some cases. MRSA may be more associated with purulent infections, perhaps owing to specific virulence factors [49] .
It is possible many cases of cellulitis are not due to infection. In the preantibiotic era, it was observed that the syndrome is often self-resolving [50, 51] . Harbinson and Lawson [50] stated, "erysipelas generally runs its course of from ten days to two weeks." A recent trial in which patients with presumed infectious cellulitis were randomized to dermatologist consultation or continued primary care found that that 90% of dermatologist's diagnoses were noninfectious conditions, and all these patients reported improvement by 1 week without antibiotics [52] .
The bacterial cause of cellulitis cannot be determined by comparing the prevalence and quantity of pathogens from infected and uninfected skin biopsy specimens with current molecular diagnostic techniques, specifically PCR and pyrosequencing. MSSA was detected but not MRSA or S. pyogenes from cellulitis tissue specimens. For now, optimal treatment will need to be guided by clinical trials. Noninfectious causes of cellulitis should also be explored.
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